Aspen: African drugmaker Aspen reports flat headline earnings

JOHANNESBURG (Reuters) - Aspen Pharmacare reported flat full-year headline earnings on Tuesday, hit by higher acquisition-related transaction costs. For the year to June 30, Africa's biggest drugmaker recorded normalised headline earnings per share of 14.92 rand, largely unchanged from the 14.98 rand reported a year earlier. The company declared a gross dividend of 359 cents per share, up 5%. (Reporting by Nqobile Dludla; Editing by David Goodman)